BACKGROUNDParsonage-Turner syndrome (PTS), also known as neuralgic amyotrophy or idiopathic brachial plexopathy, is a rare peripheral multifocal inflammatory neuropathy that usually affects the upper limbs. 1 However, it is widely misdiagnosed because of its heterogeneous clinical appearance. 2 The classic presentation is a patient with subacute-onset of asymmetric shoulder pain, followed several days later by weakness and amyotrophy. 3 Although its exact cause is still unknown, multiple factors have been identified such as immunological (infection, vaccination, surgery, pregnancy, physical, or mental stress), mechanical (trauma, sports, or heavy labor), and genetic factors. 4 In the last years, PTS has been associated with severe COVID-19 infection as well as its vaccination. 5 Therefore, we report a rare case of a subacute-onset of PTS as a result of COVID-19 vaccine.
| CASE DESCRIPTIONWe represent the case of a 50-year-old right-handed male patient, admitted to the neurology department of the Military Hospital of Tunis-Tunisia. He has no medical history of chronic diseases or medication use. He had a mild COVID-19 infection confirmed by RT-PCR on April 2021. The COVID-19 infection did not require hospitalization, nor oxygen therapy, neither other medication. He had a complete immunization schedule with no history of vaccine
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.